Funder
Innovative Medicine Initiative Joint Undertaking
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference23 articles.
1. Council for International Organizations of Medical Sciences. Practical aspects of signal detection in pharmacovigilance: report of CIOMS Working Group VIII. Geneva: Council for International Organizations of Medical Sciences; 2010.
2. Ishiguro C, Hall M, Neyarapally GA, Dal Pan G. Post-market drug safety evidence sources: an analysis of FDA drug safety communications. Pharmacoepidemiol Drug Saf. 2012;21(10):1134–6.
https://doi.org/10.1002/pds.3317
.
3. Pacurariu AC, Coloma PM, van Haren A, Genov G, Sturkenboom MCJM, Straus SMJM. A description of signals during the first 18 months of the EMA Pharmacovigilance Risk Assessment Committee. Drug Saf. 2014;37(12):1059–66.
https://doi.org/10.1007/s40264-014-0240-1
.
4. Raine JM. Risk management: a European regulatory view. In: Mann RD, Andrews EB, editors. Pharmacovigilance. 2nd ed. Chichester: Wiley; 2007. p. 553–8.
5. Mann RD, Andrews EB. Introduction. In: Mann RD, Andrews EB, editors. Pharmacovigilance. 2nd ed. Chichester: Wiley; 2007. p. 1–11.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献